|Articles|July 16, 2019
OmniComm Systems to be Acquired by Anju Software
Advertisement
OmniComm Systems, Inc. has announced that it has entered into a merger agreement with Anju Software, Inc., under which OmniComm will become a wholly owned subsidiary of Anju. The closing is expected to occur by October 31, 2019 following the satisfaction of customary closing conditions.
Find more details of the aquisition, right
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
2
Generative AI Transforms Clinical Study Report Development
3
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
4
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
